Study details
Enrolling now
Biomarkers for Exercise
NYU Langone Health
NCT IDNCT07340281ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 2 years
Ages
18–50
Locations
1 site in NY
About this study
This trial is testing whether exercise changes certain markers in the brain. Researchers will measure these markers using innovative technology to see how exercise affects anxiety.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Exercise Intervention
Primary goalInterleukin-6 (IL-6) Levels
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Interleukin-6 (IL-6) Levels
Secondary: Body Mass Index (BMI), Insomnia Severity Index (ISI) Score, Perceived Stress Scale (PSS) Score
Body systems
Psychiatry / Mental Health